Related Experiment Video
Updated: Jul 29, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Nitric oxide inhibits capping in HL-60 cells
1Department of Microbiology and Immunology, Wonkwang University School of Medicine, Chonbuk, Republic of Korea.
Nitric oxide (NO) inhibits cell capping in human promyelocytic leukemia cells by reducing actin polymerization. This finding suggests NO regulates membrane capping through intracellular F-actin formation.
Area of Science:
- Cell Biology
- Immunology
Background:
- Cell capping, a process linked to actin polymerization, is crucial for cellular functions.
- Human promyelocytic leukemia (HL-60) cells are a relevant model for studying cellular membrane dynamics.
Purpose of the Study:
- To investigate the effect of nitric oxide (NO) on cell capping in HL-60 cells.
- To determine if NO influences actin polymerization associated with capping.
Main Methods:
- HL-60 cells were treated with varying concentrations of NO.
- Cell capping was assessed using anti-human LFA-1 monoclonal antibody and fluorescence microscopy.
- F-actin content was measured using FITC-labeled phalloidin and flow cytometry.
Main Results:
- Nitric oxide (NO) demonstrated a dose-dependent inhibition of cell capping.
- Cytochalasin D, a known inhibitor of actin polymerization, also inhibited capping.
- NO treatment led to a significant decrease in intracellular F-actin formation.
Conclusions:
- Nitric oxide (NO) inhibits cell capping in HL-60 cells by reducing intracellular F-actin formation.
- Actin polymerization at the plasma membrane's inner leaflet, involved in capping, may be regulated by NO.
More Related Videos
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
07:15Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025